Final-Program-ATS-2023-AP.vp

SUNDAY • MAY 21

107

2:33 Prediction of Clinical Outcomes with Race-Specific Versus Race-Neutral Equations A.D. Baugh, MD, San Francisco, CA 2:51 Implications for Care and Impact on Health Disparities R. Adamson, MBBS, ATSF, Seattle, WA 3:09 Proposed Alternatives to Race-specific Equations: Possibilities, Pros and Cons M.C. Mccormack, MHS, MD, Baltimore, MD 3:27 Panel Discussion with Q+A N.R. Bhakta, MD, PhD, San Francisco, CA This session and the International Conference are supported by an independent medical educational grant from AstraZeneca LP, Boehringer Ingelheim Pharmaceuticals, Inc., Insmed Incorporated, and United Therapeutics Corporation. All CME sessions have been planned and implemented in accordance with the Accreditation Criteria of the Accreditation Council for Continuing Medical Education (ACCME®) and are free of the control of ineligible companies (formerly commercial interests). CLINICAL CLINICAL TOPICS IN PULMONARY MEDICINE CME Credits Available: 1.5 GREAT CASES: CLINICAL, RADIOLOGIC, AND PATHOLOGIC CORRELATIONS BY MASTER CLINICIANS Council of Chapter Representatives 2:15 PM - 3:45 PM Walter E. Washington Convention Center Ballroom C (Level 3) Target Audience Clinicians in adult and pediatric PCCM Objectives At the conclusion of this session, the participant will be able to: • describe findings based on observing master clinicians describe clinical, radiologic, and pathologic findings to challenging patient cases • describe clinical reasoning used to reach a differential diagnosis based on a multidisciplinary team model • learners will garner knowledge about treatment & management approaches to different pathologies presented at the conference Junior physicians (trainees) present interesting cases to a multidisciplinary panel to demonstrate a team approach to diagnosing and managing challenging clinical cases. It will enhance medical knowledge, and diagnostic and management skills. Chairing: M.J. Mammen, FACP, ATSF, Rochester, NY N.-C. Liang, MD, Encinitas, CA A83

2:38 Epidemic and Pandemic Viruses — Long-term Impact on Respiratory Health C. Rosas-Salazar, MD, MPH, ATSF, Nashville, TN 3:00 Wellness and Resilience H.H. De Keyser, MD, MSCR, Aurora, CO 3:23 Global Respiratory Health in the Setting of Climate Change D. Vilcins, PhD, Brisbane, Australia

CLINICAL CLINICAL TOPICS IN PULMONARY MEDICINE CME Credits Available: 1.5

A82 RACE AND PFTs: USE, CONTROVERSIES, AND ALTERNATIVES Assembly on Clinical Problems; Pulmonary Function Testing Committee 2:15 PM - 3:45 PM Marriott Marquis Washington Marquis Ballroom Salon 5 (Level M2) Target Audience Clinicians that use PFTs to diagnose or assess patients with respiratory disease, and/or clinical researchers with an interest in race or health equity Objectives At the conclusion of this session, the participant will be able to: • understand the scientific justification for, potential benefits of, and potential harms from the use of race-specific equations • improve interpretation and clinical application of PFT reports via understanding of how race-specific equations impact percent-predicted PFT values • describe potential alternatives to current interpretation strategies and race-specific GLI equations, and their impact on patient care Currently, ATS/ERS guidelines recommend the use of race-specific equations for the interpretation of spirometry. However, their use has recently been the subject of intense debate due to concerns that the equations may inappropriately normalize lower average lung function observed in Black and Asian populations. The session will present research related to why race-specific equations are used and what the potential harms and benefits of their use may be. Additionally, the session will highlight proposed alternatives to race-specific equations from the literature and discuss pros and cons of their use. Chairing: N. Thakur, MD, MPH, San Francisco, CA J.H. Brems, MD, MBE, Baltimore, MD S. Lovinsky-Desir, MD, MS, New York, NY 2:15 Race-Specific Equations: Why We Use Them, What We Know, and What We Don’t S. Stanojevic, PhD, Halifax, Canada

ATS 2023 • Washington, DC